Close Menu

ImmunoGen

NEW YORK (GenomeWeb) – Roche's Ventana Medical Systems today announced a deal with ImmunoGen to develop an immunohistochemistry-based companion diagnostic test for the oncology therapeutic firm's product candidates.

Myriad, BioMarin Ink Deal to Use HRD Test to ID Responders to PARP Inhibitor

Genomind Introduces Physician Portal for Genecept Results

The US Food and Drug Administration last week approved Roche/Genentech's latest HER2-targeting breast cancer drug, trastuzumab emtansine (T-DM1).

Biotechnology firms participating in the Alzheimer's Disease Neuroimaging Initiative have received plasma and CSF samples from ADNI participants and contributed funds for the processing of roughly 1,000 samples by biomarker discovery firm Rules-Based Medicine.

People in the News

Premium

Peter Williams

Massachusetts Biotechnology Council-BioReady Communities Campaign, Alkermes Relocation, Science + Technology Park at Johns Hopkins, Ohio State University Wright Center of Innovation in Biomedical Imaging, Londonderry Clinical Translational Research and Innovation Centre, Aeras Global TB Vaccine Foundation, BioBusiness Park at Elk Run, Chrysler-University of Delaware, ICON- Qualia Clinical Services

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.